Class I recall issued on North American Diagnostics rapid COVID-19 test

North American Diagnostics recalled a series of oral COVID-19 rapid antigen test kits, the FDA said Aug. 1.

Advertisement

The tests are designated a Class I recall, which is used for devices that may cause serious injuries or death, the agency said. They were distributed to customers without FDA authorization.

North American Diagnostics failed to provide sufficient data showing the test is accurate, the agency said.

The company is requesting that customers and distributors identify and destroy any of the unused kits, the FDA said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.